Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3462-3468

  Wood, Charles E ^a,b   Register, Thomas C ^a   Anthony, Mary S ^a   Kock, Nancy D ^a   Cline, J Mark ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ISOFLAVONE DERIVATIVE;

ARTICLE; BREAST; BREAST CANCER; CANCER RISK; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONJUGATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; FEMALE; MEDICAL ASSESSMENT; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; REDUCTION; UTERUS;

ANIMALS; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; GONADAL STEROID HORMONES; ISOFLAVONES; MACACA FASCICULARIS; MAMMARY GLANDS, ANIMAL; OVARIECTOMY; POSTMENOPAUSE; RECEPTORS, STEROID; SOYBEAN PROTEINS; SOYBEANS; UTERUS;

EQUIDAE; MACACA FASCICULARIS;

EID: 3242693966     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032067     Document Type: Article

References (58)

1. Newton KM, Buist DSM, Keenan NL, Andersen LA, LaCroix AZ 2002 Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 100:18-25
2. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA 2002 Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 23:501-509
3. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC 2002 Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23:1491-1496
4. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W 2001 Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85:372-378
5. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S 2003 Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 95:906-913
6. Ingram D, Sanders K, Kolybaba M, Lopez D 1997 Case-control study of phyto-oestrogens and breast cancer. Lancet 350:990-994
7. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA 1999 Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8:35-40
8. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN 1997 Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 146:294-306
9. Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM 2003 Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 95:1358-1364
10. Constantinou AI, Mehta RG, Vaughan A 1996 Inhibition of N-methyl-N-nitrosourea-induced mammary rumors in rats by the soybean isoflavones. Anticancer Res 16:3293-3298
11. Lamartiniere CA, Moore J, Holland M, Barnes S 1995 Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208:120-123
12. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y 1987 Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595
13. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Pecq JB, Larsen AK 1989 Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49:5111-5117
14. Barnes S, Peterson TG 1995 Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 208:103-108
15. Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I 1994 Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30:1675-1682
16. Shao ZM, Wu J, Shen ZZ, Barsky SH 1998 Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58:4851-4857
17. Constantinou AI, Kamath N, Murley JS 1998 Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer 34:1927-1934
18. Hsieh CY, Santell RC, Haslam SZ, Helferich WG 1998 Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58:3833-3839
19. Wang TT, Sathyamoorthy N, Phang JM 1996 Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17:271-275
20. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Hundred NJ 1999 Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 84:4017-4024
21. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M, Coward L 1996 Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5:785-794
22. Corner GW 1923 Ovulation and menstruation in Macacus rhesus. Contrib Embryol 15:73-102
23. Gilardi KV, Shideler SE, Valverde CR, Roberts JA, Lasley BL 1997 Characterization of the onset of menopause in the rhesus macaque. Biol Reprod 57:335-340
24. Speert H 1948 The normal and experimental development of the mammary gland of the rhesus monkey with some pathologic correlations. Contrib Embryol 32:9-65
25. Tsubura A, Hatano T, Hayama S, Morii S 1991 Immunophenotypic difference of keratin expression in normal mammary glandular cells from five different species. Acta Anatomica 140:287-293
26. Cline JM, Soderqvist G, von Schoultz B, Skoog L 1997 Regional distribution of proliferating cells and hormone receptors in the mammary gland of surgically postmenopausal macaques. Gynecol Obstet Invest 44:41-46
27. Labrie F, Belanger A, Simard J, Van L, Labrie C 1995 DHEA and peripheral androgen and estrogen formation: intracinology. Ann NY Acad Sci 774:16-28
28. Cline JM, Soderqvist G, von Schoultz E, Skoog L, von Schoultz B 1998 Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. Breast Cancer Res Treat 48:221-229
29. Cline JM, Register TC, Clarkson TB 2002 Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys. Menopause 9:422-429
30. Kaplan JR, Manuck SB, Anthony MS, Clarkson TB 2002 Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys. Obstet Gynecol 99:381-388
31. Clarkson TB, Anthony MS, Morgan TM 2001 Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 86:41-47
32. Shively CA 1998 Behavioral and neurobiological effects of estrogen replacement therapy and a history of triphasic oral contraceptive exposure. Psychoneuroendocrinology 23:713-732
33. Register TC, Jayo MJ, Anthony MS 2003 Soy phytoestrogens do not protect against bone loss in postmenopausal monkeys. J Clin Endocrinol Metab 88: 4362-4370
34. Shively CA, Mirkes SJ, Lu NZ, Henderson JA, Bethea CL 2003 Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J 3:114-121
35. Anthony MS, Clarkson TB, Bullock BC, Wagner JD 1997 Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17: 2524-2531
36. Lindholm J, van Diest PJ, Haffner D, Mikuz G, Weger AR 1992 A morphometric filter improves the diagnostic value of morphometric analyses of frozen histopathologic sections from mammary tumors. Anal Cell Pathol 4:443-449
37. Cline JM, Bain F 1995 Uterine vascular changes indicating prior pregnancy in macaques. Vet Pathol 32:585
38. Foth D, Cline JM 1998 Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 68:1413S-1417S
39. Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M 1984 Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr 40:569-578
40. Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS 2000 Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9:581-586
41. Endogenous Hormones and Breast Cancer Collaborative Group 2002 Endogenous sex hormones and breast cancer in postmenopausal women: re-analysis of nine prospective studies. J Natl Cancer Inst 94:606-616
42. Wu AH, Stanczyk FZ, Seow A, Lee HP, Yu MC 2002 Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 11:844-851
43. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS 1999 Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 84:3479-3484
44. Le Bail JC, Laroche T, Marre-Fournier F, Habrioux G 1998 Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids. Cancer Lett 133: 101-106
45. Makela S, Poutanen M, Lehtimaki J, Kostian ML, Santti R, Vihko R 1995 Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E. C. 1.1.1.62) as a possible target for the action of phytoestrogens. Exp Biol Med 208:51-59
46. Brueggemeier RW, Gu X, Mobley JA, Joomprabutra S, Bhat AS, Whetstone JL 2001 Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism. Ann NY Acad Sci 948: 51-66
47. Fritz WA, Cotroneo MS, Wang J, Eltoum IE, Lamartiniere CA 2003 Dietary diethylstilbestrol but not genistein adversely affects rat testicular develop ment. J Nutr 133:2287-2293
48. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ 1999 Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84:4559-4565
49. Khan SA, Rogers MAM, Khurana KK, Meguid MM, Numann PJ 1998 Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst 90:37-42
50. Ross RK, Paganini-Hill A, Wan PC, Pike MC 2000 Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92:328-332
51. Schairer C, Lubin J, Troisi R Sturgeon S, Brinton L, Hoover R 2000 Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283:485-491
52. Beral V, Million Women Study Collaborators 2003 Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
53. Collaborative Group on Hormonal Factors in Breast Cancer 1997 Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047-1059
54. Cline JM, Register TC, Clarkson TB 2002 Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys. Menopause 9:242-252
55. The Writing Group for the PEPI Trial 1996 Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 275:370-375
56. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D 1995 Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85:304-313
57. Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK 2002 Oral contraceptives and the risk of breast cancer. N Engl J Med 346:2025-2032
58. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development 1983 Oral contraceptive use and the risk of endometrial cancer. JAMA 249: 1600-1604